(Reuters) – The American drugstore chain Walgreens Boots Alliance said on Thursday that he had sold multiple shares of Drug distributor Cencora for about $ 300 million in revenue.
The company said it now owns a 6% stake in Cencori, reducing it with 10% earlier. He sold Cencor shares worth $ 1.1 billion in August.
Walgreens sold shares worth around $ 265 million, and Cencora agreed to buy shares worth about $ 50 million, the company statement said.
Sales sales revenues will be used primarily to pay debt and general corporate purposes, as Walgreens continues to create a strategy for capital health services rooted in its retail pharmacy.
The pharmacy chain reiterated that sales have no influence on the long -term partnership of the two companies.
.
